82 related articles for article (PubMed ID: 7653624)
1. Role of cyclooxygenase metabolites in mediating platelet-induced baroreceptor dysfunction.
Li Z; Su X; Chapleau MW
Am J Physiol; 1995 Aug; 269(2 Pt 2):H599-608. PubMed ID: 7653624
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
3. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
de Chaffoy de Courcelles D; De Clerck F
Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs.
Steudel W; Krämer HJ; Degner D; Rosseau S; Schütte H; Walmrath D; Seeger W
J Appl Physiol (1985); 1997 Jul; 83(1):18-24. PubMed ID: 9216939
[TBL] [Abstract][Full Text] [Related]
5. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
6. Aggregating human platelets in carotid sinus of rabbits decrease sensitivity of baroreceptors.
Li Z; Abboud FM; Chapleau MW
Circ Res; 1992 Apr; 70(4):644-50. PubMed ID: 1551191
[TBL] [Abstract][Full Text] [Related]
7. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
8. Platelet-induced suppression of baroreceptor activity is mediated by a stable diffusible factor.
Li Z; Chapleau MW
J Auton Nerv Syst; 1995 Jan; 51(1):59-65. PubMed ID: 7722216
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 accounts for bronchoconstriction but not for platelet sequestration and microvascular albumin exchanges induced by fMLP in the guinea pig lung.
Bureau MF; De Clerck F; Lefort J; Arreto CD; Vargaftig BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):832-40. PubMed ID: 1738127
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
McNamara DB; Harrington JK; Bellan JA; Graybar GB; Underwood DC; Kadowitz PJ
Mol Cell Biochem; 1989 Jan; 85(1):29-41. PubMed ID: 2725478
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 2. Synthesis and biological activity of 8-(benzenesulfonamido)-7-(3-pyridinyl)octaonic acid and related compounds.
Main AJ; Goldstein R; Cohen DS; Furness P; Lee W
J Med Chem; 1992 Nov; 35(23):4362-5. PubMed ID: 1447736
[TBL] [Abstract][Full Text] [Related]
12. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
[TBL] [Abstract][Full Text] [Related]
13. Bay U 3405 inhibits cerebral vasospasm induced by authentic thromboxane A2.
Braun M; Schrör K
Stroke; 1990 Dec; 21(12 Suppl):IV152-4. PubMed ID: 2260141
[TBL] [Abstract][Full Text] [Related]
14. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
Johnson GJ; Leis LA; Dunlop PC
J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
[TBL] [Abstract][Full Text] [Related]
15. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
[TBL] [Abstract][Full Text] [Related]
16. Platelet activation in carotid sinuses triggers reflex sympathoinhibition and hypotension.
Mao HZ; Li Z; Chapleau MW
Hypertension; 1996 Mar; 27(3 Pt 2):584-90. PubMed ID: 8613208
[TBL] [Abstract][Full Text] [Related]
17. Activation of TxA2/PGH2 receptors and protein kinase C contribute to coronary dysfunction in superoxide treated rat hearts.
Gupte SA; Okada T; Tateyama M; Ochi R
J Mol Cell Cardiol; 2000 Jun; 32(6):937-46. PubMed ID: 10888248
[TBL] [Abstract][Full Text] [Related]
18. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
Tesfamariam B
J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
[TBL] [Abstract][Full Text] [Related]
19. U46619 (a thromboxane A2 mimetic) induces airflow obstruction and airway plasma extravasation in the guinea pig: the role of histamine, cyclooxygenase metabolites, leukotrienes and PAF.
Kawikova I; Arakawa H; Skoogh BE; Löfdahl CG; Lötvall J
J Pharmacol Exp Ther; 1996 Jul; 278(1):268-76. PubMed ID: 8764360
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]